Device / Technology News

RSS

Chinese FDA approves Waters ACQUITY UPLC TQD system as a medical device

Waters Corporation today announced that the Chinese Food and Drug Administration (CFDA) approved the registration of the ACQUITY UPLC TQD system for legal promotion and sale in China as a medical device for routine diagnostic applications and neonatal metabolites diseases screening.

5 Jun 2014

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Cook Medical launched its Zilver PTX Drug-Eluting Peripheral Stent in Canada at the Canadian Interventional Radiology Association (CIRA) meeting in Montreal, Canada. It's the first drug-coated stent in Canada indicated to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA).

From COOK MEDICAL INC. 5 Jun 2014

INTEGRA's VIAFLO 96 handheld multichannel pipette improves efficiency of genetic screening

The Institute of Genetics and Development of Rennes, France reports on how, using a VIAFLO 96 handheld multichannel pipette from INTEGRA, they have been able to improve the efficiency and speed with which they replicate yeast strain collections and perform genetic screens in 96 well plates.

From INTEGRA Biosciences 5 Jun 2014

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Researchers at Shepherd Center are studying whether stimulating the brain before rehabilitation could yield greater gains in motor function for people recovering from stroke.

5 Jun 2014

Biosafe launches SepaMax multiprocessing device for high throughput cell processing

In line with its mission of market innovator, Biosafe is proud to announce the launch of the SepaMax multiprocessing device, on the occasion of the International Cord Blood Symposium in San Francisco.

5 Jun 2014

Symphony continuous glucose monitoring system study selected for presentation at ADA scientific sessions

Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its most recently completed clinical study of Symphony was selected for poster presentation at the 74th Scientific Sessions of the American Diabetes Association (ADA) which will be held June 13-17, 2014 in San Francisco, CA.

5 Jun 2014

TowerJazz, Genoray collaborate to develop CIS detector for medical diagnostic devices

TowerJazz, the global specialty foundry leader, and Genoray Co. Ltd., a leading manufacturer of digital X-ray devices, today announced collaboration on the successful development of a CMOS image sensor (CIS) for medical diagnostic devices such as X-ray equipment, fluoroscopy and radiography.

5 Jun 2014

Novel diagnostic tool helps differentiate between dementia diseases

A new diagnostic tool helps clinicians to differentiate between Alzheimer's disease, frontotemporal dementia and mild cognitive impairment. Presented in the doctoral thesis of MD Miguel ángel Muñoz Ruiz at the University of Eastern Finland, the new method consists of a Disease State Index combining data from multiple sources, and of a Disease State Fingerprint showing the findings in a visual format.

5 Jun 2014

Affymetrix, BioDiscovery launch new analysis software for cancer research

Affymetrix and BioDiscovery, Inc. today announced the launch of a new analysis software, Nexus Copy Number for Affymetrix, which is specifically for data generated by Affymetrix' genetic analysis platforms in cancer research, including CytoScan Cytogenetics Suite and OncoScan FFPE Assay Kit.

5 Jun 2014

Gamma and neutron imaging safe and effective in simulations

Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood.

5 Jun 2014

Disinfection caps reduce CLABSI events by 68%

Thanks to the simple use of an alcohol-impregnated cap, Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period.

5 Jun 2014

Thermo Fisher, Cellectis sign agreements on TALEN gene editing technology

Cellectis, a leader of engineered CART cell therapies, and Thermo Fisher Scientific announced today that they have entered into a series of agreements covering the uses of TAL nucleases under the brand name TALEN™.

5 Jun 2014

Klinikverbund Kempten-Oberallgäu selects iMDsoft's MetaVision to manage patient information

iMDsoft, a leader in clinical information systems, announced that Klinikverbund Kempten-Oberallgäu in Germany, a hospital with four sites in Kempten, Immenstadt, Oberstdorf and Sonthofen, chose MetaVision for all of its ICUs, intermediate care units and operating rooms.

5 Jun 2014

Scientists reproduce chromosomal modifications in human cells that cause certain cancer

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Centro Nacional de Investigaciones Oncol-gicas (CNIO) have succeeded in reproducing, in human cells, the chromosomal translocations that cause two types of cancer: acute myeloid leukemia and Ewing's sarcoma.

5 Jun 2014

Study calls for more randomized trials on e-cigarettes

E-cigarettes are a potential smoking cessation aid and they may also be able to lower the risk of nicotine dependency in high-risk groups. The available scientific evidence, however, remains insufficient.

5 Jun 2014

Elekta and Philips partner to develop integrated MRI guided radiation therapy system

Elekta and Royal Philips announced today that The Institute of Cancer Research, London, a world-leading cancer research institution, working with its clinical partner The Royal Marsden NHS Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with a mission to develop an integrated magnetic resonance imaging (MRI) guided radiation therapy system.

From Philips Healthcare 5 Jun 2014

5-question screening tool can help clinicians identify which veterans may be at risk of violence

A new brief, 5-question screening tool can help clinicians identify which veterans may be at greater risk of violence, according to a new study led by a UNC researcher.

5 Jun 2014

My Cancer Genome unveils second-generation mobile app

My Cancer Genome (MCG), an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled a free, second-generation mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.

5 Jun 2014

Novel technology to block human infections receives I-Corps grant

A novel technology developed at Worcester Polytechnic Institute (WPI) to block human infections by taking a lesson from fish has landed a $50,000 grant from the National Science Foundation's Innovation Corps (I-Corps) program.

5 Jun 2014

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions.

5 Jun 2014

Device / Technology News

Chinese FDA approves Waters ACQUITY UPLC TQD system as a medical device

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

INTEGRA's VIAFLO 96 handheld multichannel pipette improves efficiency of genetic screening

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Biosafe launches SepaMax multiprocessing device for high throughput cell processing

Symphony continuous glucose monitoring system study selected for presentation at ADA scientific sessions

TowerJazz, Genoray collaborate to develop CIS detector for medical diagnostic devices

Novel diagnostic tool helps differentiate between dementia diseases

Affymetrix, BioDiscovery launch new analysis software for cancer research

Gamma and neutron imaging safe and effective in simulations

Disinfection caps reduce CLABSI events by 68%

Thermo Fisher, Cellectis sign agreements on TALEN gene editing technology

Klinikverbund Kempten-Oberallgäu selects iMDsoft's MetaVision to manage patient information

Scientists reproduce chromosomal modifications in human cells that cause certain cancer

Study calls for more randomized trials on e-cigarettes

Elekta and Philips partner to develop integrated MRI guided radiation therapy system

5-question screening tool can help clinicians identify which veterans may be at risk of violence

My Cancer Genome unveils second-generation mobile app

Novel technology to block human infections receives I-Corps grant

STENTYS signs agreement to acquire assets of Cappella Peel Away

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News